Jason A. Segreti
Abbott Laboratories
Global Pharmaceutical Research and Development
Abbott Park
USA
Name/email consistency: high
- Tumour-selective antivascular effects of the novel anti-mitotic compound A-318315: An in vivo rat regional haemodynamic study. Segreti, J.A., Brooks, K.A., Marsh, K.C., Bauch, J.L., Lan, Y., Thomas Lin, C., Rosenberg, S.H., Sham, H.L., Reinhart, G.A., Cox, B.F., Polakowski, J.S. Clin. Exp. Pharmacol. Physiol. (2010)
- Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study. Segreti, J.A., Polakowski, J.S., Koch, K.A., Marsh, K.C., Bauch, J.L., Rosenberg, S.H., Sham, H.L., Cox, B.F., Reinhart, G.A. Cancer Chemother. Pharmacol. (2004)